Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genesis Consortium is a private life sciences investment consortium and ecosystem organization focused on supporting early-stage startups working at the intersection of human and planetary health. It was launched by SOSV and Mayfield to expand the pool of venture and corporate investors participating in biotech and related life science innovation. Rather than operating as a drug developer with an internal therapeutic pipeline, the organization functions as an alliance that helps connect founders, venture firms, corporates, and the broader early-stage life science ecosystem. Its activities appear closely linked with SOSV's IndieBio network and with investment and community-building efforts around biotechnology-enabled startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genesis Consortium.